A phase I trial evaluating NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with advanced cancers.

被引：7
|
作者：
Shen, Colette
Frakes, Jessica M.
Niu, Jiaxin
Rosenberg, Ari
Weiss, Jared
Caudell, Jimmy J.
Jameson, Katherine LaRoque
Said, Patricia
Seiwert, Tanguy Y.
机构：
[1] Univ N Carolina, Chapel Hill, NC 27515 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] Banner MD Anderson, Phoenix, AZ USA
[4] Univ Chicago, Chicago, IL 60637 USA
[5] Univ North Carolina Hosp, Chapel Hill, NC USA
[6] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[7] Nanobiotix, Paris, France
[8] Univ Chicago Med, Chicago, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.2590
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2590
引用
收藏
页数：2
相关论文
共 50 条
  • [1] NBTXR3 Activated by Radiotherapy in Combination With Nivolumab or Pembrolizumab in Patients With Advanced Cancers: A Phase I Trial
    Shen, C.
    Frakes, J. M.
    Niu, J.
    Rosenberg, A. J.
    Weiss, J.
    Caudell, J. J.
    Jameson, K.
    Said, P.
    Seiwert, T. Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E361 - E362
  • [2] NBTXR3 Activated by SBRT Combined with Nivolumab or Pembrolizumab in Patients With Advanced Cancers: Phase I Trial
    Shen, C.
    Frakes, J.
    Niu, J.
    Rosenberg, A.
    Weiss, J.
    Caudell, J.
    Jameson, K.
    Said, P.
    Seiwert, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S893 - S893
  • [3] NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in patients with advanced cancers: phase I trial
    Shen, Colette
    Frakes, Jessica
    Niu, Jiaxin
    Rosenberg, Ari
    Weiss, Jared
    Caudell, Jimmy
    Jameson, Katherine
    Said, Patricia
    Seiwert, Tanguy
    [J]. ORAL ONCOLOGY, 2021, 118
  • [4] NBTXR3 activated by SBRT combined with nivolumab or pembrolizumab in advanced cancers: phase I trial
    Vivar, O.
    Shen, C.
    Frakes, J.
    Niu, J.
    Rosenberg, A.
    Weiss, J.
    Caudell, J.
    Jameson, K.
    Said, P.
    Seiwert, T.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S28 - S28
  • [5] NBTXR3 ACTIVATED BY RADIOTHERAPY IN COMBINATION WITH NIVOLUMAB OR PEMBROLIZUMAB IN PATIENTS WITH ADVANCED CANCERS: RESULTS FROM AN ONGOING DOSE ESCALATION PHASE I TRIAL (STUDY 1100)
    Shen, Colette
    Frakes, Jessica
    Niu, Jiaxin
    Weiss, Jared
    Caudell, Jimmy
    Seiwert, Tanguy
    Said, Patricia
    Guedj, Mickael
    Tyan, Pavel
    Vivar, Omar
    Szyldergemajn, Sergio
    Farber, Leonard
    Rosenberg, Ari
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A714 - A714
  • [6] A phase I/II trial of NBTXR3 nanoparticles activated by SBRT in the treatment of liver cancers.
    Chajon, Enrique
    Pracht, Marc
    De Baere, Thierry
    Nguyen, France
    Bronowicki, Jean-Pierre
    Vendrely, Veronique
    Baumann, Anne-Sophie
    Croise-Laurent, Valerie
    Deutsch, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [7] Efficacy from the ongoing phase I trial Study 1100 with NBTXR3 activated by radiotherapy in combination with nivolumab or pembrolizumab in patients with locoregionally recurrent or metastatic HNSCC.
    Shen, Colette
    Frakes, Jessica M.
    Niu, Jiaxin
    Weiss, Jared
    Caudell, Jimmy J.
    Seiwert, Tanguy Y.
    Said, Patricia
    Tyan, Pavel
    Vivar, Omar I.
    Farber, Leonard A.
    Rosenberg, Ari
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] A phase I study of NBTXR3 activated by radiotherapy for patients with advanced cancers treated with an anti-PD-1 therapy
    Shen, C.
    Jameson, K.
    Weiss, J.
    Hackman, T.
    Corum, D.
    Akulian, J. A.
    Dixon, R.
    Pearson, A.
    Frakes, J.
    Said, P.
    Miraoui, H.
    Baskin-Bey, E.
    Seiwert, T.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [9] Phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with an anti-PD-1 therapy.
    Shen, Colette
    Frakes, Jessica
    Weiss, Jared
    Caudell, Jimmy J.
    Hackman, Trevor G.
    Akulian, Jason A.
    El-Haddad, Ghassan
    Hu, Yun
    Dixon, Robert
    Pearson, Alexander T.
    Barsoumian, Hampartsoum B.
    Cortez, Maria Angelica
    Jameson, Katherine LaRoque
    Said, Patricia
    Welsh, James William
    Seiwert, Tanguy Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] PHASE I STUDY OF INTRATUMORAL NBTXR3 IN COMBINATION WITH ANTI-PD-1 IN PATIENTS WITH ADVANCED CANCERS
    Shen, Colette
    Frakes, Jessica
    Niu, Jiaxin
    Weiss, Jared
    Caudell, Jimmy
    Jameson, Katherine
    Said, Patricia
    Seiwert, Tanguy
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A249 - A249
12345